Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial.
CONCLUSION: MPH-LA provided and maintained significant symptomatic and functional improvement in adult ADHD patients.
PMID: 24371021 [PubMed - as supplied by publisher]
Source: Advances in Therapy - Category: Drugs & Pharmacology Authors: Huss M, Ginsberg Y, Tvedten T, Arngrim T, Philipsen A, Carter K, Chen CW, Kumar V Tags: Adv Ther Source Type: research
More News: ADHD | Children | Concerta | Disability | Drugs & Pharmacology | Hyperactivity | Men | Methylphenidate | Ritalin | Statistics | Study